Insider Transactions in Q1 2025 at Mbx Biosciences, Inc. (MBX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
143,170
+6.33%
|
$1,431,700
$10.84 P/Share
|
Feb 18
2025
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
143,170
+6.33%
|
$1,431,700
$10.84 P/Share
|
Feb 14
2025
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
47,502
+0.74%
|
$427,518
$9.88 P/Share
|
Feb 14
2025
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
47,502
+0.74%
|
$427,518
$9.88 P/Share
|
Feb 04
2025
|
P. Kent Hawryluk President & CEO |
BUY
Open market or private purchase
|
Indirect |
50,000
+10.03%
|
$500,000
$10.69 P/Share
|